Introduction
============

Higher multicellular organisms, such as humans, can be considered meta-organisms constituted by the individual's own cells and their symbiotic commensal microbiota. With an estimated composition of 100 billion cells, human symbiotic microorganisms express 10 times more unique genes than those in the human genome ([@B33]). These complex communities of microorganisms, including bacteria, fungi, virus, and eukaryotic species not only enhance by several orders of magnitude the host's enzymatic capacity, but also play a key role in controlling many aspects of the individual's physiology.

In recent years, the field of immunology has been revolutionized by the growing understanding of the fundamental role of microbiota in the induction, training, and function of the host immune system ([@B6]). The immune system has evolved, to a large extent, as a means to maintain the symbiotic relationship between the host and these highly diverse and changing microbes. Under favorable conditions, the alliance between the immune system and the commensal microbiota allows the induction of protective responses against pathogens and the preservation of the regulatory pathways involved in the maintenance of tolerance to innocuous antigens ([@B16]). However, profound changes in the environmental context could lead to the selection of a microbiota that lacks the resilience and diversity needed to establish balanced immune responses ([@B50]). This suggests that environmental changes resulting from the modern lifestyle, such as antibiotic use, cesarean-section deliveries, excessive hygiene, and stress would account for the dramatic increase in autoimmune and chronic inflammatory disorders in geographical areas where the symbiotic relationship with the microbiota has been affected ([@B21]; [@B29]). Subclinical low-grade systemic inflammation has been associated with obesity, metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) ([@B45]). Several studies in animal models as well as in humans have shown that changes in the innate immune response are involved in the pathogenesis of these metabolic disorders ([@B30]; [@B11]). We have previously shown association between activity and expression levels of the toll-like receptor 4 (TLR4), a leucine-rich repeat molecule that plays a key role in the activation of innate immune response by recognizing conserved pathogen-associated molecular patterns such as lipopolysaccharides (LPS) and in metabolic disorders ([@B5]; [@B40]). The activation of TLR4 signaling induces up-regulation of inflammatory pathways related to the induction of insulin resistance. Others have highlighted the role of gut microbiota in the perpetuation of both insulin resistance and low-grade chronic inflammation ([@B41]), suggesting an alternative explanation for the increasing prevalence of insulin resistance related diseases.

There are several approaches under study to modulate the gut microbiota using external sources such as prebiotics, probiotics, antibiotics and fecal transplants ([@B3]). Probiotics are live microbial species that modulate the gut microbiota in various ways: influencing immune homeostasis, regulating mucus secretion by gut epithelial cells, facilitating the production of a variety of nutrients such as vitamins, degrading toxic substances and producing antimicrobial compounds such as bacteriocins ([@B3]). Consequently, regular probiotics consumption rapidly and reproducibly alters the human gut microbiome ([@B18]).

We are witnesses of an explosion of discoveries unveiling the role of gut microbial communities in health and disease states in humans ([@B26]; [@B20]). However, the normal composition of the microbiota of the human intestine is still under debate ([@B56]). This provides a unique opportunity to develop a comprehensive exploration of human health from a multidisciplinary research strategy. Since Buenos Aires is the second most populated agglomeration in South America and the southern hemisphere, with a large genetic and cultural component of European immigration interacting with indigenous people, we propose to describe the fingerprint of its fecal microbiota. In this sense, it is fundamental to promote research defining the microbiome in different human populations to define future therapeutic strategies for the restoration of a healthy dialogue between host and environment, and thus to restore the health of the meta- Human organism.

Materials and Methods {#s1}
=====================

Selection of Participants
-------------------------

We evaluated 30 individuals (age: 35.23 ± 8.26 years and BMI: 23.91 ± 3.4 kg/m^2^), from the general population of the Autonomous City of Buenos Aires (BA) and its metropolitan area, Argentina. The recruitment was performed in the Endocrinology Service of *Hospital de Clínicas "José de San Martín"* at Universidad de Buenos Aires, where clinic and anthropometric measurements were performed, blood samples were collected, and stool samples were received. Fecal samples were collected in household collection tubes delivered by the researchers responsible for the project. All participants signed written informed consent approved by the Ethics Committee of *Hospital Posadas*, Buenos Aires (according to the bioethical principles of the Declaration of Helsinki), approved by the Teaching, Research and Bioethics Committee of the Hospital Posadas (Ref CEPIC 119 EUPeS1/16).

### Inclusion Criteria

Volunteer individuals from the general population of the city of Buenos Aires.

### Exclusion Criteria

Individuals that have received antibiotic therapy in the last month, extreme diets (macrobiotic, vegan), gastrointestinal surgery (gastrectomy, bariatric surgery, colostomy), pregnancy, neoplasia, patients in therapy of renal replacement, transplanted or HIV patients.

Phenotypic and Environmental Data
---------------------------------

Clinical and biochemical data were evaluated as well as anthropometric measurements of the participants. Demographic characteristics, presence of environmental factors (type of delivery, feeding, consumption of probiotics, alcohol, smoking, physical activity), medication used for treatment according to the case, and family history of chronic inflammatory pathologies, and the preexistence of emerging diseases such as Obesity, T2DM, Arterial Hypertension, Dyslipidemia among others, were established by anamnesis.

Sample Collection and DNA Extraction
------------------------------------

During the interview participants were instructed in the collection method for stool sampling by receiving a standardized written protocol for the collection of approximately 5 g of stool in a sterile wide-mouth tube in DMSO/EDTA/saturated sodium chloride buffer (DESS buffer) ([@B27]). DESS Buffer has been shown to be highly effective in long-term DNA preservation at room temperature ([@B4]). Tubes had a small spoon attached to the lid that facilitates the collection of the samples, which were suggested to be collected within 24 h prior to the next interview. Stool samples received were kept at -80°C until use. For each sample, DNA extraction was performed from 200 mg of feces using two different commercial kits following the instructions of the manufacturers: QIAamp DNA Stool Mini Kit (QIAGEN^®^) and Quick-DNA Soil (Zymo Research^®^). Nucleic acid concentration and purity were determined by 1% agarose gel electrophoresis and spectrophotometry on a NanoDrop ND-1000 (NanoDrop Technologies, Wilmington, DE, United States).

Sequencing of Bacterial 16S rRNA Fragments
------------------------------------------

To amplify 16S rRNA gene fragments, 30 ng of purified DNA was used and the hypervariable regions V3 and V4 of the bacterial 16S gene were amplified using Bakt_341F/Bakt_805R primers contained Illumina overhang adapter sequences. Sequencing was performed using a MiSeq sequencer (Illumina^®^). Libraries were sequenced in paired-end mode, guaranteeing sequences of ∼550 bp long and ∼100.000 sequences per sample.

Sequence Analysis and Comparison of Microbial Communities
---------------------------------------------------------

De-multiplexed reads were quality trimmed using Trimmomatic (V0.36) ([@B9]). Sequences generated were analyzed using quantitative insights into microbial ecology (QIIME) version 1.9.1 software package ([@B12]) for the identification of operative taxonomic units (OTUs) as well as taxonomic allocation and statistical analysis. To this end, the sequences obtained were compared with those deposited in Greengenes 13_8 database ([@B19]). Chimeric sequences were filtered using VSEARCH ([@B44]). Phylum, Class, Family, and Gender were assigned to each reading with an *open_reference* OTU picking process (with sortmerna_coverage of 80%) ([@B31]). Additionally, to compare this dataset with other studies that targeted different 16S regions, closed-reference strategy was used. In order to normalize the subsequent bioinformatic analysis raw sequences from different dataset were used. In particular, we compare our population with the following 16S rRNA gene sequence data set: Healthy Cohort study-Production Phase 2(PP2) of human microbiome project (HMP) SRP002860 ([@B54]); Rosario-Argentina ([@B13]); Hadza population from Tanzania ([@B46]); Bologna-Italia ([@B46]) and Santiago-Chile ([@B46]; [@B23]). The sequences obtained in this study were forwarded and made available in Qiita database (ID 11839) and SRA: PRJNA503303. To account for multiple comparisons, *p*-values were adjusted by Benjamini--Hochberg FDR correction, applied separately at each taxonomic rank for a given comparison ([@B7]). To study microbial communities in different sample groups we used Unifrac algorithm ([@B36]), specially designed to describe and compare microbial communities based on massive sequencing of phylogenetic marker genes. In order to compare this dataset with other studies that targeted different 16S regions closed_reference strategy was used. Differences on beta diversity were assessed using ADONIS. Ellipses drawings for weighted UniFrac and unweighted UniFrac were performed using cov.dellipse from metRology R package.

Putative functional genes were predicted using PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) ([@B32]), which applies 16S rRNA gene to predict the abundance of functional genes by matching sample OTUs with reference genomes. In order to compare the relative abundance of the different taxa between groups, we performed linear discriminant analysis (LDA) effect implemented in LEfSe ([@B48]).

Results
=======

Buenos Aires General Population Data
------------------------------------

Buenos Aires and its metropolitan area constitute a megalopolis, being the second most populated agglomeration in South America and the southern hemisphere with 12.806.866 of inhabitants. According to the last census (2010), the average age of the Autonomous City of Buenos Aires (BA) is 39.66 years. As reported by the "Third National Survey of Risk Factors for Non-transmissible Diseases" (NSRF) of the National Ministry of Health performed in 2013 ([@B53]), the average daily servings of fruits or vegetables consumed per person in the general population of BA was 2.1, being below the amount recommended by WHO (five daily servings of fruits and/or vegetables). The highest averages of daily fruit or vegetable consumption were recorded in the oldest age group (2.4), in the highest education level (2.1) and higher income level. In addition, the prevalence of overweight individuals was 32% (IC 95% 27.6 -- 36.8), the prevalence of high cholesterol among those who were once controlled (population 18 years and older) was 27.9% (IC 95% 24.0 -- 32.1), and 8.2% marked the prevalence of diabetes in the total adult population (IC 95% 6.4 -- 10.5).

We evaluated 30 individuals (Female/male: 15/15; age: 35.23 ± 8.26 years and BMI: 23.91 ± 3.4 kg/m^2^), from the general population of BA ([Table 1](#T1){ref-type="table"}).

###### 

Anthropometric and biochemical data of the 30 volunteers.

                                      Mean     SD
  ----------------------------------- -------- -------
  Female/male                         15/1     
  Age (years)                         35.23    8.26
  Weight (kg)                         69.48    12.82
  Height (m)                          170.17   9.73
  Body mass index (kg/m^2^)           23.91    3.40
  Glycemia (mg/dl)                    80.48    11.33
  Triglycerides (mg/dl)               75.24    20.48
  Total cholesterol (mg/dl)           168.24   29.80
  High density lipoproteins (mg/dl)   55.10    17.06
  Low density lipoproteins (mg/dl)    168.23   29.80
                                               

Samples Collection and Storage
------------------------------

Considering that several methods could be used for stool collection and storage, we standardized sample collection and storage protocol prior processing. In our population based study, participants were instructed in a home collection method for stool sampling, proved to be as effective as freshly collected native stool ([@B47]). This strategy comes from the preference of most participants who do not agree to collect the stool samples elsewhere. Therefore, each participant received a written protocol for easy stool collection, consisting in introducing approximately 5 g of stool in a sterile wide-mouth tube with DESS buffer ([@B27]). This solution preserves the samples both at room temperature and in sub-zero conditions, avoiding freezing and cell damage. Additionally, DESS buffer is a non-proprietary solution that has been used for DNA preservation ([@B24]) as it guarantees long term storage at room temperature (up to 24 weeks), and has been used to preserve bacterial DNA from coral mucus swabs for up to 4.5 months ([@B39]). Additionally, given that it is known that freezing and thawing the samples could generate OTUs identification bias ([@B22]), this buffer represents an efficient alternative strategy for adequate sampling and preservation until processing.

DNA Extraction Method
---------------------

DNA isolation protocol and the targeted 16S rRNA gene region sequence chosen for analysis have been shown to be critical for gut microbiota assessment ([@B58]), limiting the ability to compare different human microbiome datasets. In other to evaluate possible biases in the 16S profiles related to DNA extraction method, we compare QIAamp DNA Stool Mini (QG) and Quick-DNA Soil (ZR) commercial kits. DNA extraction was performed from 200 mg of feces using both QG and ZR for each sample. Fecal DNA extraction using QC and ZR yielded an average of 49.59 ± 21.41 and 24.85 ± 20.75 μg/mL DNA, respectively. The hypervariable regions V3-V4 of bacterial 16S gene was sequenced using MiSeq-Illumina system, and an average of 47526 ± 4718 sequences per sample were obtained. Rarefaction plots reach an asymptotic state, indicating that the sequence depth was sufficient to represent the bacterial community richness and diversity by both methods (data not shown). In this sense, when we compare alpha diversity (Chao1 index) based on a two-sample *t*-test, there are not significant differences between QG and ZR kits (*p* = 0.069). We also found no significant differences when comparing beta diversity between different purification kits, *p* = 0.97 for weighted UniFrac and unweighted UniFrac *p* = 0.294 (ADONIS).

Comparing the principal phyla detected using both DNA extraction Kits, we found that the choice of DNA extraction method has an impact on the observed community structure. Using the QG kit, the dominant phyla were Bacteroidetes (47.7 ± 8.9%), Firmicutes (37.2 ± 8.45%), Proteobacteria (8.5 ± 6.7%), Verrucomicrobia (2.5 ± 2.8%) and Actinobacteria (1.3 ± 2.2%), while the principal phyla found using ZR kit were Firmicutes (45.5 ± 8.8%), and Bacteroidetes (40.0 ± 7.8%), followed by Proteobacteria (6.1 ± 5.4%), Verrucomicrobia (2.5 ± 3.0%), and Actinobacteria (3.1 ± 2.2%). In this sense, QG protocol, without the bead-beating step, resulted in a significantly low abundance in Gram-positive phyla, Firmicutes (*p* = 0.015); Actinobacteria (*p* = 9.29 × 10^-5^) and overestimated Bacteroidetes phyla (*p* = 0.023) FDR adjusted *p*-values. These results, in accordance with previous studies ([@B28]; [@B59]), show that DNA extraction method has an impact on the observed community structure. In particular, the first step of DNA extraction bead-beating disruption and/or lysis of the bacterial membranes can be expected to be biased for specific bacterial taxa due to differences in cell wall structure and integrity.

Since several studies have proposed the Firmicutes to Bacteroidetes ratio (F/B:ratio) as a gauge of short-chain fatty acids (SCFA) production and the overall gut microbiota balance any bias in these parameters must be taken into account ([@B42]; [@B25]). In particular, QG protocol showed an increase in the abundance of Bacteroidetes phylum, main acetate and propionate producers, and a decrease in Firmicutes butyrate-producers ([@B37]). It is important to remark that these changes impact notably the F/B: ratio, being 0.77 for QG kit vs. 1.13 for ZR one. However, it is not possible to determine which DNA extraction method best represents the overall microbial community.

Analysis of BA Microbiota
-------------------------

Our data is consistent with previous observations showing that the regular intake of yogurt and other fermented products promotes a healthy gut microbiota ([@B34]; [@B38]; [@B52]). In this sense we found significant differences in alpha diversity Chao1 index (*p* = 0.012) when comparing microbial diversity between subjects that habitually consume probiotics with those who do not (considering both extraction kits).

To further analyze our results, we compared the microbiota of BA with other westernized populations (Santiago de Chile, Rosario-Argentina, United States-Human-microbiome-project, Bologna-Italy) and the Hadza population of hunter-gatherers ([Table 2](#T2){ref-type="table"}). To understand differences in the composition of microbial communities' diversity among environments was compared. Beta diversity (considering weighted and unweighted UniFrac distances) was analyzed in order to compare the differences between microbial compositions among different populations ([Figure 1](#F1){ref-type="fig"}). Differences on beta diversity values between habitats, countries, cities, 16S region amplified, purification kit employed, and platform were evaluated (ADONIS). Although all the comparisons were statistically significant (*p* \< 0.001), the *R*^2^-value indicates that approximately 43% (weighted) and 23% (unweighted) of the variation effect is produced by the city of origin, being the most important variable studied. The unweighted UniFrac (a qualitative measure that estimates the distance between two communities) clustered the westernized populations together, leaving the hunter-gatherer population from Hadza out. In particular, Santiago de Chile's population turns out to be the closest to BA's.

###### 

Data-sets included in the analysis.

  Platform                 Country         City                     Purification \_kit                                                      Region   Center_name                                                                                          Habitat            Publication
  ------------------------ --------------- ------------------------ ----------------------------------------------------------------------- -------- ---------------------------------------------------------------------------------------------------- ------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------
  454 LifeSciences-Roche   Tanzania        Tanzania-Lake Eyasi      QIAmp DNA Stool Mini Kit (Qiagen)                                       V4       Metabolism Anthropometry and Nutrition Laboratory Department of Anthropology University of Nevada.   Hunter-Gathe rer   Gut microbiome of the Hadza hunter-gatherer s_doi: 10.1038/n comms4654
  454 LifeSciences-Roche   Italy           Italy-Bologna            QIAmp DNA Stool Mini Kit (Qiagen)                                       V4       Metabolism Anthropometry and Nutrition Laboratory Department of Anthropology University of Nevada.   Westernized        Gut microbiome of the Hadza hunter-gatherer s_doi: 10.1038/n comms4681
  MiSeqSytem -Illumina     Argentina       Argentina-Buenos_Aires   QIAmp DNA Stool Mini Kit (Qiagen) and Quick-DNA Soil (Zymo Research).   V3-V4    GeC-UNLu                                                                                             Westernized        Buenos Aires microbiome
  MiSeqSytem -Illumina     Chile           Chile-Santiago           QIAmp DNA Stool Mini Kit (Qiagen)                                       V3-V4    Centro de Genética y Genómica                                                                        Westernized        The Gut Microbiota of Healthy Chilean Subjects Reveals a High Abundance of the Phylum Verrucomicrobi a: <https://doi.org/10.3389/fmicb.2017.01221>
  454 LifeSciences-Roche   Argentina       Argentina-Rosario        QIAmp DNA Stool Mini Kit (Qiagen)                                       V1-V3    INDEAR                                                                                               Westernized        Human Microbiota of the Argentine Population- A Pilot Study: <https://doi.org/10.3389/fmicb.2016.00051>
  454 LifeSciences-Roche   United States   United States            MoBio Powersoil Kit                                                     V3-V5    Human Microbiome Project (HMP)                                                                       Westernized        Healthy Cohort study:Productio n Phase 2(PP2)-SRP002 860
                                                                                                                                                                                                                                                                             

![PCoA of beta diversity values (unweighted and weighted Unifrac distances). Comparison of the gut microbiota from individuals of BA and other geographic locations. Ellipses were showed confidence interval of 95%.](fmicb-10-00965-g001){#F1}

It is relevant to highlight that the microbiota of BA subjects stands out for the presence of Verrucomicrobia of the genus *Akkermansia* (1.2%). The mucus-degrading bacterium *Akkermansia* muciniphila is the only identified member of this genus and was also found in the Chilean population ([@B23]). This microorganism has been proposed by others as a hallmark of a healthy gut due to its anti-inflammatory and immunostimulant properties and its ability to improve gut barrier function, insulin sensitivity and endotoxemia ([@B17]; [@B8]). However, some studies report the induction of pro-inflammatory responses triggered by *Akkermansia* contributing to an increase of inflammation during infection in Multiple Sclerosis patients ([@B15]). As proposed by Fujio-Vejar et al., these results could serve as a baseline for the characterization of dysbiosis associated with various diseases ([@B23]; [Figure 2](#F2){ref-type="fig"}).

![Community composition of gut microbiome from each geographic location shown at the phylum level.](fmicb-10-00965-g002){#F2}

Putative functional genes were predicted using PICRUSt which applies 16S rRNA gene to predict the abundance of functional KEEG pathways. The LDA effective size (LEfSe) was performed to identify KEEG pathways with statistically differential abundance between hunter-gatherers and westernized population. The results show that metabolism related pathways were more abundant in westernized populations than in hunter-gatherers. In particular, carbohydrate metabolism (amino sugar and nucleotide sugar metabolism), amino acid metabolism (alanine, aspartate and glutamate metabolism), lipid metabolism, biosynthesis of secondary metabolites, and sulfur metabolism showed a LDA score greater than 2.0 ([Figure 3](#F3){ref-type="fig"}).

![Linear discriminant analysis (LDA) effect size (LEfSe) analysis of the differentially abundant KEEG pathways in hunter-gatherers vs. westernized population. The threshold of the logarithmic LDA score was 2.0.](fmicb-10-00965-g003){#F3}

Discussion
==========

The intestine harbors a sophisticated ecosystem of microbial communities, exerting vital metabolic functions that contribute to the recovery of nutrients and energy from non-digestible substrates. Microbial colonization is essential for the normal development of the immune system, regulating the homeostasis between environmental antigenic load and immune response. In susceptible individuals, imbalance could result into pathologies of immune dysregulation, including chronic inflammatory bowel diseases and metabolic syndrome, in which the immune system overreacts to non-harmful microbial antigens ([@B1]; [@B10]). Although there are new molecular technologies, the normal composition of the microbiota of the human intestine is still under debate ([@B56]). Many environmental factors, such as geographic localization, household characteristics and circumstances as delivery method, antibiotic use, breastfeeding or diet in the early life, are conditioning factors for microbial colonization of the intestine. In permissive genetic backgrounds, environmental reprogramming of microbiota can trigger conditions for the establishment of an imbalanced immune response ([@B55]).

The number of public human metagenomes shows a marked bias toward the north hemisphere. Analyzing the total metagenomic data available today, the northern hemisphere outnumbers that from the south by 200 times. Since Buenos Aires is the second most populated agglomeration in South America and the southern hemisphere, with a large genetic and cultural component of European immigration interacting with indigenous people, we propose to describe the fingerprint of its fecal microbiota. Given the hypothesis that there are differences between the intestinal microbiota composition of healthy and diseased subjects, we proposed to draw a baseline study of the uncharacterized gut microbiota from the general population of BA for future comparisons with any further studies.

During the interviews, participants were instructed in the home collection method of stool sampling, which was suggested to be collected within the 24 h prior to the next interview. Stool samples were remitted and stored at -80°C until use. In order to prevent changes in fecal microbiota, 16S gene sequencing profiles related to ambient temperature ([@B43]; [@B14]) or sub-zero storage conditions ([@B2]; [@B22]) sampling was performed in a sterile wide-mouth tube with DESS buffer, since performing the nucleic acid extraction of samples immediately after collection was impractical. DESS buffer showed to be particularly efficient for sample transfer and storage at -80°C until processing, and it allowed the adequate conservation of the samples.

DNA extraction could also add to methodological biases in PCR amplification due to the presence of contaminants that could inhibit the reaction or the efficiency in DNA purification. Additionally, disruption and/or lysis of the bacterial membranes could be another source of bias, as it may favor the presence of specific bacterial taxa due to differences in cell wall structure and integrity ([@B49]; [@B57]). We have chosen two worldwide used commercial kits in order to evaluate microbiota profile sampling. Indeed, we observed differences in two of the most abundant phyla, Firmicutes and Bacteroidetes, which were differently affected, showing the effect of the extraction methods between Gram-positive and Gram-negative bacterial membranes. Interestingly, when we compare alpha diversity no significant differences between kits were observed. We also found no significant differences when comparing beta diversity, for weighted UniFrac and unweighted UniFrac, between purification methods. Although principal phyla were detected using both kits, we found that the choice of DNA extraction method has an impact on the observed community structure. In particular, these notably alter the F/B ratio, not allowing determining which DNA extraction method is the best to represent the microbial community. In addition, when we compare the microbiota of BA with other populations, we observed differences on beta diversity values between habitats, countries, cities, 16S region amplified, Purification Kit employed and Platform. Although all the comparisons were statistically significant, the *R*^2^-value indicates that approximately 43% (weighted) and 23% (unweighted) of the variation effect is produced by the city of origin, being the most important variable studied. However, when taxa abundance, such as F/B ratio, is analyzed between different studies the purification method must be taken into account. In this sense, future gold standard purification method should be developed to sort this bias to allow accurate conclusions.

In order to evaluate similarities and differences within other populations, we compare our microbiome with other westernized populations and the Hadza population of hunter-gatherers. The unweighted UniFrac, that estimate the distance between two communities, clustered together all westernized populations leaving the hunter-gatherer population from Hadza out. This Qualitative measure which uses only the presence/absence of data is most informative when communities differ primarily by which microorganism can live in them ([@B35]). Additionally, unweighted UniFrac can better detect effects of different founding populations, such as the source of bacteria that first colonize the gut of newborns and the effects of restrictive factors for microbial growth. In contrast, quantitative measures that account for the relative abundance of microbial lineages can reveal the effects of more transient factors.

In this sense, the microbiota of BA subjects stands out for the presence of the mucus-degrading bacterium *Akkermansia* muciniphila, the only identified member of its genus. This microorganism, also found in the Chilean population, has been proposed as a hallmark of a healthy gut due to its anti-inflammatory and immunostimulant properties and its ability to improve gut barrier function, insulin sensitivity and endotoxemia ([@B17]; [@B23]).

Finally, westernized populations showed more abundant metabolism related KEEG pathways than hunter-gatherers, including carbohydrate metabolism (amino sugar and nucleotide sugar metabolism), amino acid metabolism (alanine, aspartate and glutamate metabolism), lipid metabolism, biosynthesis of secondary metabolites and sulfur metabolism. This could be due to feeding habits since Hadza diet consists only of wild foods that fall into five main categories: meat, honey, baobab, berries and tubers ([@B46]).

Environmental factors, such as lifestyle, diet, the use of antibiotics, and the host genotype affects the human microbiome. It is important to point out that most of the available studies evaluate European, Asian, and North American populations that significantly differ both in the genetic background and in diverse environmental factors with BA population. On the contrary, very little is known about the microbiome of the Argentinean population, in particular there is currently only a pilot study of the population of Rosario city, Santa Fe ([@B13]). It was then essential to know in depth the characteristic metagenome of the residents of BA and its metropolitan area which constitute a megalopolis, being the second most populated agglomeration in South America and the southern hemisphere with 12.806.866 of inhabitants.

In this sense, it is crucial to identify specific groups of the intestinal microbiota that could affect the susceptibility and/or severity of disease by stimulating chronic inflammatory responses ([@B51]). Diversity among environments, genotypes and, therefore, microbial factors of the intestinal flora between human populations make it difficult to find ubiquitous biomarkers worldwide. Knowing the microbiota composition of the general BA population provides a framework to have a local reference that will allow establishing future correlations between health and disease. This is essential, not only for evaluating changes in the gut microbiota regarding different social habits and clinical features, but also to contribute to the development of personalized nutritional and pharmacological strategies to promote a healthy intestinal flora.
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